A new risk model to predict time to first treatment in chronic lymphocytic leukemia based on heavy chain immunoparesis and summated free light chain

Author:

Tadmor Tamar12ORCID,Braester Andrei34,Najib Dally5,Aviv Ariel6,Herishanu Yair78ORCID,Yuklea Mona9,Shvidel Lev10,Rahimi‐Levene Naomi11,Ruchlemer Rosa12,Arad Ariela13,Fogl Claudia14,Henig Clara15,Barak Mira15,Magal Lee16,Polliack Aaron13,Townsend Kelly14,

Affiliation:

1. Bnai Zion Medical Center Haifa Israel

2. The Ruth and Bruce Rappaport Faculty of Medicine Technion Haifa Israel

3. Western Galilee Hospital Nahariya Israel

4. Bar Ilan University Ramat Gan Israel

5. Ziv Medical Center Safed Israel

6. Emek Medical Center Afula Israel

7. Tel‐Aviv Sourasky Medical Center Tel Aviv Israel

8. Tel‐Aviv University Tel Aviv Israel

9. Meir Medical Center Kfar Saba Israel

10. Kaplan Medical Center Rehovot Israel

11. Assaf Harofeh Medical Center Be'er Ya'akov Israel

12. Shaare Zedek Medical Center Jerusalem Israel

13. Department of Hematology Hadassah‐Hebrew University Medical Center Jerusalem Israel

14. The Binding Site Group Ltd Birmingham UK

15. Haifa and Western Galilee Laboratory Nesher Israel

16. Almog Diagnostic Park Shoham Israel

Publisher

Wiley

Subject

Hematology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3